Abstract

BackgroundThe treatment of Multidrug-Resistant Tuberculosis represents one of the most significant challenges to global health. Despite guidance on improving treatment outcomes, there is little focus on how to support individuals in their suffering. Palliative care is therefore proposed as a necessary component in the global strategy to fight Tuberculosis. We aim to describe the informal resources and networks available to persons affected by Multidrug-Resistant Tuberculosis, how they are accessed and how they are integrated into everyday lives.MethodsIn-depth ethnographic research was conducted in Bengaluru, India. Informal interactions and observations were recorded across a range of palliative care and tuberculosis treatment providers over a month-long period. In addition, ten individuals with Multidrug-Resistant Tuberculosis were asked for in-depth interviews, and five agreed.ResultsMultidrug-Resistant Tuberculosis caused a dynamic chain of events that transgress through physical and psychological domains to cause human suffering. Participants utilised support from their family and friends to build a network of care that was of therapeutic benefit. Informal care networks were similar to the holistic model of care practice by specialist palliative care services and represent an underused resource with enormous potential.ConclusionPatient suffering is poorly addressed in current Tuberculosis treatment programmes. A community-based palliative care approach may extend peoples’ support networks, helping to alleviate suffering. Further research on existing support structures and integration of these services into Tuberculosis control programmes is required.

Highlights

  • The treatment of Multidrug-Resistant Tuberculosis represents one of the most significant challenges to global health

  • Conceptual framework and literature review A conceptual framework was created to guide the study and data analysis. This was based upon the initial literature review, which demonstrated the structural components of a palliative care programme and how these may accommodate the different modalities of suffering experienced

  • Human context of disease Realms of suffering The medical management of MDR-TB was found to occur in the context of profound human suffering

Read more

Summary

Introduction

The treatment of Multidrug-Resistant Tuberculosis represents one of the most significant challenges to global health. We aim to describe the informal resources and networks available to persons affected by Multidrug-Resistant Tuberculosis, how they are accessed and how they are integrated into everyday lives. MDR-TB has a global treatment success rate of 55%, whilst extensively drug resistant TB (XDR-TB), a subset of MDR-TB with added resistance to fluoroquinolones and second line injectable drugs, is at 34% [1]. These statistics only partially tell the story as many people are left

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call